Editors:
Elucidates the current status of hormone therapy for prostate cancer
Clarifies the differences between the evidence from Japan and that from Western countries on hormone therapy for prostate cancer
Broadens the reader’s understanding of castration-resistant prostate cancer
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (43 chapters)
-
Front Matter
About this book
This comprehensive reference expounds the current state of hormone therapy and castration resistance of prostate cancer (PCa). Previously, the incidence of PCa in Asian countries was relatively low, but it has been increasing dramatically in recent years. Although most of the new cases are diagnosed in early stages, a significant proportion of patients receive hormone therapy for metastatic disease or for relapse after local treatment. Thus the situation has gradually changed toward earlier and longer use of hormone therapy. The malignancy finally forms castration-resistant prostate cancer (CRPC) despite the lack of testicular androgen. With advances in understanding of the molecular basis of hormone dependence and CRPC, many new androgen receptor-targeted agents have emerged.
During the last decade, much evidence on hormone therapy has been accumulated in Japan. Interestingly, some of these findings are different from those reported from Western countries, suggesting ethnic variation in the outcome of hormone therapy. In the chapters of this book, expert authors provide exhaustive interpretations of the evidence recently reported from Japan and provide important Asian perspectives on hormone therapy for PCa. This work benefits not only Asian urologists but also their Western counterparts and all physicians and medical personnel who are involved in the treatment of PCa.
Reviews
Editors and Affiliations
-
Department of Urology, Tohoku University School of Medicine, Sendai, Japan
Yoichi Arai
-
Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Osamu Ogawa
About the editors
Dr. Yoichi Arai,
Professor and Chairman,
Department of Urology,
Tohoku University School of Medicine
Dr. Osamu Ogawa,
Professor and Chairman,
Department of Urology,
Kyoto University Graduate School of Medicine
Bibliographic Information
Book Title: Hormone Therapy and Castration Resistance of Prostate Cancer
Editors: Yoichi Arai, Osamu Ogawa
DOI: https://doi.org/10.1007/978-981-10-7013-6
Publisher: Springer Singapore
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Nature Singapore Pte Ltd. 2018
Hardcover ISBN: 978-981-10-7012-9Published: 28 May 2018
Softcover ISBN: 978-981-13-3906-6Published: 25 December 2018
eBook ISBN: 978-981-10-7013-6Published: 11 May 2018
Edition Number: 1
Number of Pages: VIII, 433
Number of Illustrations: 31 b/w illustrations, 34 illustrations in colour